Advanced Science · 2021 · 66 citations · 53 references
MedicineNeurosciencePharmacologyDrug DeliveryNanoparticle Drug DeliveryNeuropharmacologyBlood-brain Barrier PenetrationBrain Targeted DeliveryNanomaterials For Drug DeliveryNeurodegenerative DiseasesNeurodegenerative DisordersNeuroprotectionBlood-brain Barrier PermeabilityDopaminergic Neuron DeathNeuroprotective AgentsNeuroprotective MechanismsParkinsonian NeuroprotectionTargeted DeliveryTargeted Delivery Across The Blood-brain BarrierTargeted Delivery Systems
Parkinson's disease (PD) is characterized by the progressive deterioration of dopamine (DA) neurons, and therapeutic endeavors are aimed at preventing DA loss. However, lack of effective brain delivery approaches limits this strategy. In this study, a "Trojan horse" system is used for substantia nigra-targeted delivery of a blood brain barrier-penetrating peptide (RVG29) conjugated to the surface of nanoparticles loaded with the natural autophagy inducer 4,4'-dimethoxychalcone (DMC) (designated as RVG-nDMC). Here, the neuroprotective effects of DMC are demonstrated in PD. Specifically, RVG-nDMC penetrates the blood brain barrier with enhanced brain-targeted delivery efficiency and is internalized by DA neurons and microglia. In vivo studies demonstrate that RVG-nDMC ameliorates motor deficits and nigral DA neuron death in PD mice without causing overt adverse effects in the brain or other major organs. Moreover, RVG-nDMC reverses tyrosine hydroxylase ubiquitination and degradation, alleviates oxidative stress in DA neurons, and exerts antiinflammatory effects in microglia. The "Trojan horse" strategy for targeted delivery of DMC thus provides a potentially powerful and clinically feasible approach for PD intervention.
53
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
Julian Fearnley, Andrew J. Lees · Brain · 1991 · 3.5K citations
The substantia nigra of the human brain
Philippe Damier, Étienne C. Hirsch, Yves Agid et al. · Brain · 1999 · 1.8K citations
Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution
Takahiro Masuda, Roman Sankowski, Ori Staszewski et al. · Nature · 2019 · 1.4K citations · Full text
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Jeffrey H. Kordower, C. Warren Olanow, Hemraj B. Dodiya et al. · Brain · 2013 · 1.3K citations · Full text